Skip to content
About Us
Overview
Leadership
Board of Directors
Scientific Advisory Board
Our Approach
Pipeline
Overview
Publications
Clinical Trials
Investors
Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs
Contact
About Us
Overview
Leadership
Board of Directors
Scientific Advisory Board
Our Approach
Pipeline
Overview
Publications
Clinical Trials
Investors
Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs
Contact
Letter to the Editor: Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial
Download PDF
View Resource
Scroll to Top
Secret Link